Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Differential function of STAT5 isoforms in head and neck cancer growth control

Abstract

Up-regulation of the epidermal growth factor receptor (EGFR) is critical for the loss of growth control in a variety of human cancers, including squamous cell carcinoma of the head and neck (SCCHN). Stimulation of EGFR results in activation of mitogenic signaling pathways including Signal Transducers and Activators of Transcription (STATs). Stat5 activation has been primarily demonstrated in hematopoietic malignancies. Gene disruption studies suggest potentially distinct functions of the Stat5 isoforms, Stat5a and Stat5b, which are encoded by two genes closely linked on human chromosome 17. To determine the function of Stat5 in SCCHN growth control, we studied the expression and constitutive activation of Stat5a and Stat5b in normal and transformed human squamous epithelial cells. Increased constitutive activation of Stat5 was detected in transformed compared with normal squamous cells. Blockade of TGF-α or EGFR, abrogated Stat5 activation. Targeting of Stat5b using antisense oligonucleotides inhibited SCCHN growth. In addition, SCCHN cells stably transfected with dominant negative mutant Stat5b failed to proliferate in vitro. In contrast, targeting of Stat5a using either antisense or dominant negative strategies had no effect on cell growth. These results suggest that TGF-α/EGFR-mediated autocrine growth of transformed epithelial cells is dependent on activation of Stat5b but not Stat5a.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820

  • Carpenter G . 1992 FASEB J. 6: 3283–3289

  • Chai SK, Nichols GL, Rothman P . 1997 J. Immunol. 159: 4720–4728

  • Christensen ME, Therkildsen MH, Hansen BL, Albeck H, Hansen GN, Bretlau P . 1992 Eur. Arch. Otorhinolaryngol. 249: 243–247

  • Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G . 2000 Clin. Cancer Res. 6: 2053–2063

  • Copeland NG, Gilbert DJ, Schindler C, Zhong Z, Wen Z, Darnell Jr JE, Mui AL, Miyajima A, Quelle FW, Ihle JN et al . 1995 Genomics 29: 225–228

  • Darnell Jr JE . 1997 Science 277: 1630–1635

  • de Groot RP, Raaijmakers JA, Lammers JW, Jove R, Koenderman L . 1999 Blood 94: 1108–1112

  • Endo S, Zeng Q, Burke NA, He Y, Melhem MF, Watkins SF, Lango MN, Drenning SD, Huang L, Rubin Grandis J . 2000 Gene Ther. 7: 1906–1914

  • Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ . 1994 Science 265: 1093–1095

  • Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L . 1996 Blood 87: 1692–1697

  • Grandis JR, Chakraborty A, Zeng Q, Melhem MF, Tweardy D . 1998a J. Cell. Biochem. 69: 55–62

  • Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy D . 1998b J. Clin. Invest. 102: 1385–1392

  • Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD . 2000 Proc. Natl. Acad. Sci. USA 97: 4227–4232

  • Grandis JR, Melhem MF, Barnes EL, Tweardy D . 1996a Cancer 78: 1284–1292

  • Grandis JR, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ . 1998c J. Natl. Cancer Inst. 90: 824–832

  • Grandis JR, Tweardy DJ . 1993a Cancer Res. 53: 3579–3584

  • Grandis JR, Tweardy DJ . 1993b J. Cell. Biochem Suppl., ?? 188–191

  • Grandis JR, Zeng Q, Tweardy DJ . 1996b Nat. Med. 2: 237–240

  • Hayakawa F, Towatari M, Iida H, Wakao H, Kiyoi H, Naoe T, Saito H . 1998 Br. J. Haematol. 101: 521–528

  • Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB, Whiteside TL . 1989 Cancer Res. 49: 5167–5175

  • Hernandez-Sotomayor SM, Carpenter G . 1992 J. Membr. Biol. 128: 81–89

  • Ihle JN, Kerr IM . 1995 Trends Genet. 11: 69–74

  • Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM . 1999 J. Biol. Chem. 274: 22484–22492

  • Kazansky AV, Rosen JM . 2001 Cell Growth Differ. 12: 1–7

  • Kumar V, Bustin SA, McKay IA . 1995 Cell Biol. Int. 19: 373–388

  • Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA . 2000 Blood 95: 2076–2083

  • Lango MN, Shin DM, Grandis JR . 2001 Curr. Opin. Oncol. 13: 168–175

  • Levy DE, Gilliland DG . 2000 Oncogene 19: 2505–2510

  • Lin JX, Mietz J, Modi WS, John S, Leonard WJ . 1996 J. Biol. Chem. 271: 10738–10744

  • Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L . 1997 Genes Dev. 11: 179–186

  • Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ . 1995 Science 269: 79–81

  • Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F . 1996 Mol. Cell. Biol. 16: 5691–5700

  • Nieborowska-Skorska M, Slupianek A, Skorski T . 2000 Oncogene 19: 4117–4124

  • Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . 1999 J. Exp. Med. 189: 1229–1242

  • Okuda K, Golub TR, Gilliland DG, Griffin JD . 1996 Oncogene 13: 1147–1152

  • Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE . 1999 J. Biol. Chem. 274: 17209–17218

  • Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A, Kitamura T . 1998 Mol. Cell. Biol. 18: 3871–3879

  • Rubin Grandis J, Chakraborty A, Melhem MF, Zeng Q, Tweardy DJ . 1997 Oncogene 15: 409–416

  • Sacks PG, Parnes SM, Gallick GE, Mansouri Z, Lichtner R, Satya-Prakash KL, Pathak S, Parsons DF . 1988 Cancer Res. 48: 2858–2866

  • Sadowski HB, Shuai K, Darnell Jr JE, Gilman MZ . 1993 Science 261: 1739–1744

  • Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD . 1995 Exp. Hematol. 23: 1040–1048

  • Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR, Lee CK, Gerthner R, Kitamura T, Frantsve J, Anastasiadou E, Loh ML, Levy DE, Ihle JN, Gilliland DG . 2000 Mol. Cell 6: 693–704

  • Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF, Ihle JN . 2000 Blood 96: 2277–2283

  • Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksal H, Mendelsohn J, Hong WK . 2001 Clin. Cancer Res. 7: 1204–1213

  • Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . 1996 Oncogene 13: 247–254

  • Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF . 1999 Cell 98: 181–191

  • Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, Leonard WJ . 2000 Mol. Cell. Biol. 20: 389–401

  • Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW . 1997 Proc. Natl. Acad. Sci. USA 94: 7239–7244

  • Virolainen E, Carey TE, Wicha M, Krause CJ . 1983 Otolaryngol. Head Neck Surg. 91: 126–135

  • Wakao H, Gouilleux F, Groner B . 1994 EMBO J. 13: 2182–2191

  • Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J . 1996 Blood 88: 809–816

  • Wong P, Severns CW, Guyer NB, Wright TM . 1994 Mol. Cell. Biol. 14: 914–922

Download references

Acknowledgements

This work was supported by National Institutes of Health grant CA77308 (to JR Grandis).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer Rubin Grandis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leong, P., Xi, S., Drenning, S. et al. Differential function of STAT5 isoforms in head and neck cancer growth control. Oncogene 21, 2846–2853 (2002). https://doi.org/10.1038/sj.onc.1205385

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205385

Keywords

This article is cited by

Search

Quick links